Mithra Pharmaceuticals - Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator)
12 mai 2023 11h45 HE
|
Mithra Pharmaceuticals
Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator) Liege, Belgium, 12 May 2023 – 17:50 CET – Mithra Pharmaceuticals SA...
Mithra Announces Completion of Recruitment in Pediatric Study of Estelle in Adolescent Patients
11 mai 2023 01h30 HE
|
Mithra Pharmaceuticals
Mithra Announces Completion of Recruitment in Pediatric Study of Estelle in Adolescent Patients Trial designed to address limited clinical data in this population despite widespread use of Combined...
Mithra and the University of Liège Secure Proof-of-Concept for Novel Manufacturing Process of Estetrol
04 mai 2023 01h30 HE
|
Mithra Pharmaceuticals
Collaboration demonstrates Mithra’s commitment to innovation and sustainable drug supply in Women’s Health Liege, Belgium, 04 May 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company...
Publication of a transparency notification received from Alychlo NV
28 avr. 2023 11h45 HE
|
Mithra Pharmaceuticals
Liege, Belgium, 28 April 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007...
Mithra Releases Invitation to its General Shareholders’ Meeting
25 avr. 2023 01h30 HE
|
Mithra Pharmaceuticals
Mithra Releases Invitation to its General Shareholders’ Meeting Liege, Belgium, 25 April 2023 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces...
Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA
26 nov. 2018 02h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...